Topical therapy with imiquimod for eyelid lesion

被引:7
作者
Tsang, HH [1 ]
Huynh, NT
Hollenbach, E
机构
[1] John Hunter Hosp, Eye Clin, Newcastle, NSW, Australia
[2] Royal Newcastle Hosp, Dermatol Clin, Newcastle, NSW, Australia
关键词
Bowen's disease; eyelid tumours; imiquimod; skin neoplasms;
D O I
10.1111/j.1442-9071.2006.01177.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Herein a case of clinically diagnosed lower eyelid lesion treated with topical imiquimod is reported. Macroscopic resolution of the lesion occurred 4 weeks after treatment with good cosmetic result. This is the first reported successful case of using this drug in treating eyelid lesion involving the lid margin.
引用
收藏
页码:179 / 181
页数:3
相关论文
共 11 条
[1]  
ARTLETTE JP, 2003, BR J DERMATOL S66, V149, P43
[2]   Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream [J].
Chen, K ;
Shumack, S .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 :10-12
[3]   Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies [J].
Geisse, J ;
Caro, I ;
Lindholm, J ;
Golitz, L ;
Stampone, P ;
Owens, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (05) :722-733
[4]   Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials [J].
Lebwohl, M ;
Dinehart, MB ;
Whiting, D ;
Lee, PK ;
Tawfik, N ;
Jorizzo, J ;
Lee, JH ;
Fox, TL .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (05) :714-721
[5]   Imiquimod 5% cream in the treatment of Bowen's disease [J].
Mackenzie-Wood, A ;
Kossard, S ;
de Launey, J ;
Wilkinson, B ;
Owens, ML .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (03) :462-470
[6]   Treatment of lentigo maligna with topical imiquimod [J].
Naylor, MF ;
Crowson, N ;
Kuwahara, R ;
Teague, K ;
Garcia, C ;
Mackinnis, C ;
Haque, R ;
Odom, C ;
Jankey, C ;
Cornelison, RL .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 :66-69
[7]   Two cases of squamous cell carcinoma treated with topical imiquimod 5% [J].
Oster-Schmidt, C .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2004, 18 (01) :93-95
[8]   Topical imiquimod immunotherapy in the management of lentigo maligna [J].
Powell, AM ;
Russell-Jones, R ;
Barlow, RJ .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (01) :15-21
[9]   Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod [J].
Schön, M ;
Bong, AB ;
Drewniok, C ;
Herz, J ;
Geilen, CC ;
Reifenberger, J ;
Benninghoff, B ;
Slade, HB ;
Gollnick, H ;
Schön, MP .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) :1138-1149
[10]   Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy [J].
Smith, KJ ;
Germain, M ;
Skelton, H .
DERMATOLOGIC SURGERY, 2001, 27 (06) :561-564